<--- Back to Details
First PageDocument Content
Atypical ductal hyperplasia / Lobular carcinoma in situ / Cancer / Breast disease / Breast / Carcinoma in situ / Breast cancer awareness / Mammary ductal carcinoma / Medicine / Oncology / Breast cancer
Date: 2014-06-09 10:20:21
Atypical ductal hyperplasia
Lobular carcinoma in situ
Cancer
Breast disease
Breast
Carcinoma in situ
Breast cancer awareness
Mammary ductal carcinoma
Medicine
Oncology
Breast cancer

Add to Reading List

Source URL: www.cdc.gov

Download Document from Source Website

File Size: 674,07 KB

Share Document on Facebook

Similar Documents

Journal of Machine Learning ResearchSubmitted 8/15; Revised 3/16; PublishedStructure-Leveraged Methods in Breast Cancer Risk Prediction

DocID: 1vq0d - View Document

Multicausality: Confounding - Assignment solutions 1. a. Reserpine is a risk factor. Overall, the incidence of breast cancer isper 100,000 women-years in reserpine users and 6.14 per 100,000 women-years in nonuser

DocID: 1vpNA - View Document

Breast Implant Associated Lymphoma What To Tell Your Patients A special information evening to be presented by

DocID: 1vp5j - View Document

Frequently Asked Questions: Trainees seeking a PhD education in Cancer Biology or a related area with a focus on Breast Cancer Health Disparities. 1. What is the Komen Graduate Training in Disparities Research Grant (GT

DocID: 1voV1 - View Document

_____________________________________________________________ What to Do When Someone You Know Has Been Diagnosed with Breast Cancer [Last revised Mar 2014]

DocID: 1vlqg - View Document